Tower Research Capital LLC (Trc) Bluejay Diagnostics, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.19 - $0.41 $13 - $28	-70 Reduced 0.69%	10,132 $2,000
Q1 2023 May 09, 2023	SELL	$0.38 - $0.87 $3 - $7	-9 Reduced 0.09%	10,202 $4,000
Q4 2022 Feb 10, 2023	SELL	$0.34 - $138.99 $457 - $187,080	-1,346 Reduced 11.65%	10,211 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.83 - $132.53 $9,592 - $1.53 Million	11,557 New	11,557 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.63 $6,691 - $11,603	-7,119 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.86 - $2.92 $5,927 - $20,124	6,892 Added 3036.12%	7,119 $8,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.32 $528 - $1,207	227 New	227 $1,000

Ticker BJDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,152,300
Market Cap $71.3M
Description
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.